Abstract
We report three heterozygous PROS1 mutations that caused type I protein S deficiency in three unrelated Chinese families. We measured protein S activity and antigen levels for all participants, screened them for mutations in the PROS1 gene. And we employed the calibrated automated thrombin generation (CAT) method to investigate thrombin generation. Numerous bioinformatics tools were utilized to analyze the conservation, pathogenicity of mutation, and spatial structure of the protein S. Phenotyping analysis indicated that all three probands exhibited simultaneous reduced levels of PS:A, TPS:Ag, and FPS:Ag. Genetic testing revealed that proband A harbored a heterozygous c.458_458delA (p.Lys153Serfs*6) mutation in exon 5, proband B carried a heterozygous c.1687C>T (p.Gln563stop) mutation in exon 14, and proband C exhibited a heterozygous c.200A>C (p.Glu67Ala) mutation in exon 2. Bioinformatic analysis predicted that the p.Lys153Serfs*6 frameshift mutation and the p.Gln563stop nonsense mutation in the protein S were classified as “disease-causing.” The identification of the novel mutation p.Lys153Serfs*6 in PROS1 enriches the Human Genome Database. Our research suggests that these three mutations (p.Lys153Serfs*6, p.Gln563stop, and p.Glu67Ala) are possibly responsible for the decreased level of protein S in the three families. Furthermore, the evidence also supports the notion that individuals who are asymptomatic but have a family history of PSD can benefit from genetic analysis of the PROS1 gene.
Similar content being viewed by others
Data availability
The data that support the conclusions of this study are available from the corresponding author upon request. Further inquiries can be directed to the corresponding author.
Abbreviations
- PROS1 gene:
-
protein S1 gene
- PSD:
-
protein S deficiency
- CAT:
-
calibrated automated thrombin generation
- PS:A:
-
protein S activity
- TPS:Ag:
-
total protein S antigen
- FPS:Ag:
-
free protein S antigen
- PC:
-
protein C
- APC:
-
activated PC
- TFPI:
-
tissue factor inhibitor
- VTE:
-
venous thromboembolism
- MRI:
-
magnetic resonance imaging
- CT:
-
computed tomography
- PE:
-
pulmonary embolism
- MRV:
-
magnetic resonance venography
- PT:
-
prothrombin time
- APTT:
-
activated partial thromboplastin time
- D-D:
-
D-dimer
- PC:A:
-
protein C activity
- AT:A:
-
anti-thrombin activity
- PPP:
-
platelet-poor plasma
- ELISA:
-
enzyme-linked immunosorbent assay
- TGT:
-
thrombin generation test
- ETP:
-
endogenous thrombin potential
- sTM:
-
soluble recombinant human thrombomodulin
- PCR:
-
polymerase chain reaction
- PDB:
-
Protein Data Bank
- EGF:
-
epidermal growth factor
- LGR:
-
liver growth factor
- TSR:
-
thrombin-sensitive region
- PF:
-
purpura fulminans
References
Juhl D, Kuta P, Shneyder M et al (2021) Two novel variants in the protein S gene PROS1 are associated with protein S deficiency and thrombophilia. Acta Haematol 144(2):222–226. https://doi.org/10.1159/000508525
Ameku K, Higa M (2018) Rivaroxaban treatment for warfarin-refractory thrombosis in a patient with hereditary protein S deficiency. Case Rep Hematol 23(2018):5217301. https://doi.org/10.1155/2018/5217301
Miyata T, Maruyama K, Banno F et al (2016) Thrombophilia in East Asian countries: are there any genetic differences in these countries? Thromb J 14(Suppl 1):25. https://doi.org/10.1186/s12959-016-0109-x
Majumder R, Nguyen T (2021) Protein S: function, regulation, and clinical perspectives. Curr Opin Hematol 28(5):339–344. https://doi.org/10.1097/MOH.0000000000000663
Majid Z, Tahir F, Ahmed J et al (2020) Protein C deficiency as a risk factor for stroke in young adults: a review. Cureus 12(3):e7472. https://doi.org/10.7759/cureus.7472
Wypasek E, Undas A (2013) Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med 22(4):459–467
Gierula M, Ahnström J (2020) Anticoagulant protein S-new insights on interactions and functions. J Thromb Haemost 18(11):2801–2811. https://doi.org/10.1111/jth.15025
Takeyama M, Nogami K, Saenko EL et al (2008) Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa. Br J Haematol 143(3):409–420. https://doi.org/10.1111/j.1365-2141.2008.07366.x
Khan F, Tritschler T, Kahn SR et al (2021) Venous thromboembolism. Lancet 398(10294):64–77. https://doi.org/10.1016/S0140-6736(20)32658-1
Labrouche-Colomer S, Soukarieh O, Proust C et al (2020) A novel rare c.-39C>T mutation in the PROS1 5′UTR causing PS deficiency by creating a new upstream translation initiation codon. Clin Sci (Lond) 134(10):1181–1190. https://doi.org/10.1042/CS20200403
Li L, Wu X, Wu W et al (2023) A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency. Thromb J 21(1):52. https://doi.org/10.1186/s12959-023-00494-3
Zhou J, Shen W, Gu Y et al (2020) Compound heterozygous mutations identified in severe type I protein S deficiency impaired the secretion of protein S. J Clin Pathol 73(1):7–13. https://doi.org/10.1136/jclinpath-2019-205956
Ikejiri M, Wada H, Yamada N et al (2017) High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism. Int J Hematol 105(3):272–279. https://doi.org/10.1007/s12185-016-2111-2
Maurissen LF, Castoldi E, Simioni P et al (2010) Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals. J Thromb Haemost 8(4):750–758. https://doi.org/10.1111/j.1538-7836.2010.03743.x
Schweingruber C, Rufener SC, Zünd D et al (2013) Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim Biophys Acta 1829(6-7):612–623. https://doi.org/10.1016/j.bbagrm.2013.02.005
Hackeng TM, Yegneswaran S, Johnson AE et al (2000) Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S. Biochem J 349(Pt 3):757–764. https://doi.org/10.1042/bj3490757
Yamazaki T, Hamaguchi M, Katsumi A et al (1995) A quantitative protein S deficiency associated with a novel nonsense mutation and markedly reduced levels of mutated mRNA. Thromb Haemost 74(2):590–595
Biguzzi E, Razzari C, Lane DA et al (2005) Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. Hum Mutat 25(3):259–269. https://doi.org/10.1002/humu.20136
Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous thrombosis. N Engl J Med 344(16):1222–1231. https://doi.org/10.1056/NEJM200104193441607
ten Kate MK, van der Meer J (2008) Protein S deficiency: a clinical perspective. Haemophilia 14(6):1222–1228
Siegal DM, Eikelboom JW et al (2021) Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries. Cardiovasc Res 117(2):576–584. https://doi.org/10.1093/cvr/cvaa044
Mizukami K, Nakabayashi T, Naitoh S et al (2006) One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis. Am J Hematol 81:787–797. https://doi.org/10.1002/ajh.20689
Phillippe HM, Hornsby LB, Treadway S et al (2014) Inherited thrombophilia. J Pharm Pract 27(3):227–233. https://doi.org/10.1177/0897190014530390
Stevens SM, Woller SC, Bauer KA et al (2016) Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis 41(1):154–164. https://doi.org/10.1007/s11239-015-1316-1
Colvin BT, Machin SJ, Barrowcliffe TW et al (1993) Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol 46(12):1069–1070. https://doi.org/10.1136/jcp.46.12.1069
Funding
This work was funded by the Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province (2022E10022) and the Science and Technology Plan Fund of Wenzhou (Y20220125).
Author information
Authors and Affiliations
Contributions
All the authors have made significant contributions to the study’s conception and design, data acquisition, analysis and interpretation, as well as to the drafting and critical revision of the manuscript for important intellectual content. Furthermore, all the authors have provided their final approval for the submitted version of the article.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xu, F., Zhou, X., Jin, Y. et al. Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency. Ann Hematol 103, 653–662 (2024). https://doi.org/10.1007/s00277-023-05607-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-023-05607-6